Skip to content

Big Pharma Split Corp Class A

🇨🇦XTSE.PRMCanadaFinancial Services

CA$31.11CADdown -0.29 (-0.92%)ClosedEnd of day3:04 AM

PriceCA$31.11-0.29 (-0.92%)

Latest anomalies

Neutral 0 detected in the last 120 days

  • High: 6
  • Medium: 7
  • Low: 0
  • Debt to assets: a sudden spike above its trailing quarter average

    Fundamentals High

  • Debt to equity: a sudden spike above its trailing quarter average

    Fundamentals High

  • Effective tax rate: a sudden spike above its trailing quarter average

    Fundamentals Medium

  • Financial leverage: a sudden spike above its trailing quarter average

    Fundamentals Medium

  • Net profit margin: a sudden drop below its trailing quarter average

    Fundamentals Medium

View all anomalies

Free with a Finzer account.

Profile

  • Financial Services
  • Asset Management
  • Canada

Identity

Type
Stock
ISIN
CA08934P1080
CUSIP
08934P108

Company

Employees
0
Headquarters
Oakville, Canada

Market

Shares outstanding
1.2M
Market cap
CA$37.83M

Highlights

Day rangeCA$30.54 - CA$31.77
today's session
52-week rangeCA$19.70 - CA$34.89
from 164 sessions
Market cap
CA$37.83M
EPS LTM
-CA$0.41
P/E LTM
-19.80
Div yield
13.54%

Fundamentals (LTM)

Revenue
CA$481.22K-95.16%down year on year
Net income
-CA$968.03K-127.01%down year on year
Gross margin
35.88%-63.32%down year on year
Free cash flow
CA$5.51M+378.09%up year on year

View all financials

Latest news

News is not sourced for this exchange.

Business summary

Big Pharma Split Corp Class A is a company in the financial services sector, listed on Toronto Stock Exchange (Canada) under the ticker PRM. Its market capitalisation is CA$37.83M, from 1.2M shares outstanding, as of . Across the 164 trading sessions to the shares traded between CA$19.70 and CA$34.89, and the last close of CA$31.11 sits 75% of the way up that range. The company is headquartered in Oakville, Canada.

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.